Nature Cell Biology 7, 1202 - 1212 (2005)
Published online: 27 November 2005; | doi:10.1038/ncb1326
There is an Erratum (December 2005) associated with this Article.
Polycystin-1 and polycystin-2 regulate the cell cycle through the helix–loop–helix inhibitor Id2Xiaogang Li1, Ying Luo1, Patrick G. Starremans1, Coleen A. McNamara2, York Pei3
& Jing Zhou11
Renal Division, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA. 2
Cardiovascular Division, Department of Internal Medicine, University of Virginia Health Sciences Center, Charlottesville, VA 22908, USA. 3
Division of Nephrology, Department of Medicine, Toronto Hospital and University of Toronto, Toronto, Ontario M5G2C4, Canada.
Correspondence should be addressed to Jing Zhou zhou@rics.bwh.harvard.edu Autosomal-dominant polycystic kidney disease (ADPKD) is the most common hereditary kidney disease and is characterized by progressive cyst formation and ultimate loss of renal function. Increased cell proliferation is a key feature of the disease. Here, we show that the ADPKD protein polycystin-2 (PC2) regulates the cell cycle through direct interaction with Id2, a member of the helix–loop–helix (HLH) protein family that is known to regulate cell proliferation and differentiation. Id2 expression suppresses the induction of a cyclin-dependent kinase inhibitor, p21, by either polycystin-1 (PC1) or PC2. The PC2–Id2 interaction is regulated by PC1-dependent phosphorylation of PC2. Enhanced Id2 nuclear localization is seen in human and mouse cystic kidneys. Inhibition of Id2 expression by RNA interference corrects the hyperproliferative phenotype of PC1 mutant cells. We propose that Id2 has a crucial role in cell-cycle regulation that is mediated by PC1 and PC2.
MORE ARTICLES LIKE THIS These links to content published by NPG are automatically generated.
|
